Increasing prevalence of metabolic disorders and high healthcare expenditure is expected to drive the demand for United States clinical nutrition market for the forecast period.
According to TechSci Research report, “United States Clinical Nutrition Market By Nutrition Type (Enteral Nutrition v/s Parental Nutrition) By Route of Administration (Oral v/s Intravenous) By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary fiber, Antioxidants) By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others) By End User (Infant & Child, Adults, Geriatrics) By Company, By Region, Forecast & Opportunities, 2026”, United States clinical nutrition market is expected to witness significant growth for the next five years. Clinical nutrition is a kind of pharmaceutical product which is taken to keep the patient healthy. It aids in improving the metabolic system of the body by providing supply of supplementary vitamins and minerals, among others. Increase in the number of birth rates and premature birth require the use of clinical nutrition.
The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Demand for immunity booster alternatives as a preventive measure from being affected by coronavirus witnessed surge in the growth. Old age people and children after getting infected with coronavirus suffers lack of appetite along with diarrhea, anosmia dysgeusia both of which can increase the risk of malnutrition. Malnutrition can lead to lower defense levels of the body and loss of muscles which can affect the health of the patient adversely. Therefore, the clinical nutrition market is expected to be positively impacted with the onset of coronavirus pandemic.
However, lack of awareness about the benefits of clinical nutrition may create hindrance in the clinical nutrition market growth.
Browse XX Figures spread through XX Pages and an in-depth TOC on “United States Clinical Nutrition Market”.
United States clinical nutrition market is segmented into nutrition type, route of administration, substrate, application, end user, regional distribution, and company. Based on application, market is further divided into metabolic disorders, eating disorders, stages of development and recovery and others. The metabolic disorders segment is expected to dominate the clinical nutrition marker for the forecast period, 2022-2026. People getting infected by coronavirus require the dosage of clinical nutrition to prevent the cases of malnutrition. Lack of some essential vitamins and minerals gives rise to a number of diseases and rise in awareness among people is contributing to raise the growth of the clinical nutrition market in United States. Based on end user, market is majorly categorized into infant & child, adults, and geriatrics. The infant & child segment is anticipated to hold major market share for the next five years. Rise in number of premature births and malnourished babies is driving the growth of the market. Introduction of infant nutritional products by the major market players and organization of camps and programs to raise the awareness about the importance of clinical nutrition is fostering the demand for clinical nutrition in United States.
Nestle USA, Danone USA, Abbott Nutrition Ltd., Fresenius Kabi USA, Inc., Baxter International, Inc., B Braun USA, Conmed Corporation, Vesco Medical LLC, Pfizer Inc., Otsuka America Pharmaceutical Inc. are the leading players operating in US clinical nutrition market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several clinical nutrition manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7488
Customers can also request for 10% free customization on this report.
“Increase in occurrence of cancer and diabetes along with rising old age population is fueling the need for adoption of clinical nutrition in regular diets suffering from chronic diseases are deprived from the presence of few essential nutrition. Adoption of unhealthy eating habits and sedentary lifestyle is contributing to the rise in number of obese populations in United States. Manufacturers are selling clinical nutrition products through online platforms along with offering of lucrative discounts to widen the reach of products and sales of clinical products which is further expected to propel the clinical nutrition market growth until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Clinical Nutrition Market By Nutrition Type (Enteral Nutrition v/s Parental Nutrition) By Route of Administration (Oral v/s Intravenous) By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary fiber, Antioxidants) By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others) By End User (Infant & Child, Adults, Geriatrics) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of United States clinical nutrition market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States clinical nutrition market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017